Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Cracking the genetic code in MND

Original source

Cracking the genetic code in MNDMotor Neurone Disease Association (UK) · 12 March 2024 (opens in a new tab)

Related topics

A study using Project MinE data found that 6% of people with motor neurone disease (MND) carried variants in more than one MND-associated gene. These people had shorter survival and faster progression, particularly when one variant was in C9orf72. The study found no difference in age at disease onset.

Why this matters

The findings suggest that assessing several MND-related genes together may improve understanding of prognosis. This is a genetic research finding and does not currently change treatment for people with MND.

Limitations and context

The evidence is described in an organisation’s blog about research presented at an international symposium, not in a primary research paper supplied here. The source does not provide the study’s full sample size, methods, statistical results or peer-review status. It also does not establish that genetic testing based on these findings improves outcomes or should be used to guide treatment.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?